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The lung's response to deposited particles may depend upon the physical-chemical properties of the particles, the amount initially deposited, and
the persistence of the particles. Clearance involves mucociliary transport as well as the action of phagocytic cells in nonciliated regions of the lung.
Depending on the animal species studied, particle type, and particle load, inorganic materials are ingested by macrophages on alveolar surfaces with
half-times of 0.6 to 7 hr. Particle-laden macrophages may migrate to airways, but we believe that an important mechanism of clearance is the disso-
lution of particles within alveolar macrophages and the subsequent translocation of dissolved materials to the blood. Particle dissolution in situ has
long been recognized but was often thought to be carried out extracellularly in the alveolar lining layer, airway mucus, or interstitial fluid. However,
many particles such as cobalt oxide or iron oxide which dissolve very little in simulated lung fluid, are solubilized more rapidly within alveolar
macrophages. Clearance of particles from the lungs can be followed by a number of techniques, both invasive and noninvasive. The approaches
vary in expense and resolution, and can be directed toward quantifying mechanical removal of particles versus their intracellular dissolution.
Noninvasive methods permit repeated measurements of particle retention in the lungs of the same animal or human and thus allow replications and
serial measurements. Greater precision with respect to the sites of retention and redistribution is achieved with quantitative morphometric methods
that utilize fixation followed by physically dividing the respiratory tract into individual pieces. Microwave drying or slam-freezing can eliminate the
possibility of significant particle redistribution or loss of particles and dissolved elements during tissue processing. Detection of particles and there-
fore evidence of clearance can rely upon any distinctive property of the aerosol. Particles may be radioactive, fluorescent, or magnetic, or may have
a characteristic visual appearance. Detection techniques include radiography, analyses of radioactivity, magnetometry, and microscopic approaches
such as fluorescence and confocal microscopy, X-ray emission analysis, and electron energy loss spectrometry (EELS). Using these approaches,
considerable evidence has been accumulated to conclude that particle dissolution in situwithin alveolar macrophages and subsequent absorption by
the circulation, rather than bulk transport, is the dominant mechanism for the long-term clearance of many insoluble minerals from the lungs. -
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Introduction
The lung's response to aerosols depends
not only on the amount of particles
deposited but also on the amount retained
over time. Retention is the amount of
material present in the lungs at any time
and equals deposited mass minus cleared
mass. An equilibrium concentration of
retention is reached during continuous
exposure to aerosols when the rate ofdepo-
sition equals the rate of clearance.
Clearance may represent either bulk,
mechanical transport from the airways and
parenchyma, or solubilization and the
removal of individual ions or molecules by
body fluids. Both the amount of particles
retained within a specific lung region over
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time and those properties of the retained
particles determine the magnitude of the
response.
Deposition influences subsequent fate
since where particles deposit in the lungs
determines the mechanisms used to clear
them, how fast they are cleared, and the
amount retained over time. Examples of
the implications of particle characteristics
on integrated retention have been
described (1) based on a model developed
by the Task Group on Lung Dynamics
(2). Calculations show that the total
amount as well as the distribution of
retained dose between nose and pharynx,
trachea and bronchi, and the pulmonary
and lymphatic compartments are dramati-
cally altered byparticle size and solubility.
This article begins with a brief review
of the fate of particles deposited either in
the conducting airways or on alveolar sur-
faces. The mechanisms responsible for par-
ticle clearance are summarized with
particular emphasis on the fate of nonfi-
brous inorganic particles. We then discuss
a number ofnew methods that are particu-
larly useful in describing the fate of parti-
cles deposited in the respiratory tract.
Airways: Mucociliary
Transport
Many inhaled particles will deposit on the
liquid-covered conducting airways that
serve as conduits for inspired air. Such air-
ways are well populated with cells contain-
ing cilia. These ciliated epithelial cells of
the airways and nasal passages are covered
by a complex multilayered mucus blanket.
Early models describe a top, high-viscosity
gel layer and a bottom, low-viscosity serous
layer. The gel mucus blanket along with
any less-soluble particles that deposit on it
are moved toward the pharynx by the cilia.
Also present in this moving mucus carpet
are cells and particles that have been
deposited there or transported from the
nonciliated alveoli to the ciliated airways.
Mucus, cells, and debris from the nasal
cavities and lungs meet at the pharynx, mix
with salivary secretions, and enter the gas-
trointestinal tract after being swallowed. In
humans the ciliated epithelium extends
from the trachea to the terminal bronchi-
oles. The particles are removed with half-
times of minutes to hours but may be
retained much longer. The speed of the
mucus blanket is faster in the trachea than
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in the small airways and is affected by fac-
tors influencing either the cilia or the
amount and quality of mucus. In the air-
ways there is less time for solubilization of
slowly dissolving materials because of
mucociliary transport. In contrast particles
deposited in the nonciliated compartments
may have longer residence times.
Ciliary action may be affected by the
number of strokes per minute, the ampli-
tude of each stroke, the time course and
form ofeach stroke, the length ofthe cilia,
the ratio ofciliated to nonciliated area, and
the susceptibility of the cilia to intrinsic
and extrinsic agents that modify their rate
and quality of motion. The characteristics
ofthe mucus layer are critically important.
The thickness of the mucus layer and its
rheological properties may vary widely. In
the peripheral bronchioles, for example, the
gel layer is less evident. Many ofthe factors
that influence mucociliary clearance have
been reviewed (2,3).
Many investigators have estimated
mucociliary transport from whole lung
clearance curves. These curves are gener-
ated by monitoring the amount ofradioac-
tivity in the lungs over time (hours to days)
following the inhalation of a radiolabeled
aerosol. This method, when first used,
indicated that the clearance curve could be
divided into a fast phase and a slow phase
(5). The fast phase is complete within 24
to 48 hr and generally has been attributed
to tracheobronchial clearance; the slow
phase has been attributed to alveolar clear-
ance (6). However, later evidence indicates
that clearance from the airways is incom-
plete in the first 24 hr (7); this may be
even more pronounced in patients with
lung disease. Later, it was noted that parti-
cles instilled into the trachea could be
sequestered in epithelial cells (8). Latex
particles were found trapped in the pericil-
iary sol fluid below the gel mucus blanket
(9). The particles may have been displaced
there by surface tension forces created by
surfactant (10,11). Both fast and slow
phases of clearance were noted even in
humans given a bolus of aerosol particles
delivered only 45 ml beyond the larynx
(12). When radiolabeled particles were
delivered with a bronchoscope to airway
generations 6 to 10 in dogs, it was found
that about 20% of the particles were
cleared slowly (12).
Cough also operates to remove particles
trapped in mucus when mucociliary trans-
port is compromised or overwhelmed.
After a series of coughs one often notices
an accumulation ofmucus in or just below
the pharynx. How did the mucus get there?
Was it pushed along as a film or carried
suspended in the airstream? There is
detailed information concerning the flow
ofgas during cough (13), but we also need
to consider the flow ofmucus. The impor-
tance of mucus rheology to mucus trans-
port is appreciated, but for cough we also
need to consider coupling between gas and
liquid and how these are affected by mucus
viscosity, surface tension, elasticity, and
thickness (15). Yet, we do not know pre-
cisely which rheological properties are
appropriate. What characteristics ofmucus
enhance mucus transport? The problem is
complicated by the fact that mucus is a
highly non-Newtonian material. The vis-
cosity of mucus varies over three orders of
magnitude as the shear rate varies, so one
needs to knowwhat shear rates exist in situ
during cough to evaluate these strategies
properly.
Bronchial Circulation and the
Redistribution of Deposited
Dose
Ions and molecules from soluble particles
that land on the airway surfaces and dis-
solve can pass through the mucus layer and
enter the circulation. So may solubilized
components from particles that enter air-
way cells and are dissolved intracellularly.
These materials then can leave the lungs,
but some portion also may be carried via
the circulation to other lung regions.
Although the extent of this redistribution
by the lung's circulation is still unclear, it
could deliver solubilized materials beyond
initial deposition sites and lead to accumu-
lation elsewhere, such as sites in the
parenchyma or airwaycartilage.
The lung has two blood supplies: the
pulmonary circulation, which nourishes
the parenchymal tissues, and the smaller
bronchial circulation, which nourishes the
airways from the trachea to the terminal
bronchioles as well as the associated nerves,
lymph nodes, and supporting tissues
including the esophagus (16). As the main
bronchial arteries enter the lungs they fol-
low the branching pattern of the airways.
From the arteries arise a series ofarterioles
and then capillaries that form an extensive
vascular bed in the mucosa under the air-
way epithelium. The capillary bed drains
into numerous postcapillary venules in the
mucosa and then to underlying collecting
venules and veins (17,18). In sheep, rab-
bits, and possibly humans, the collecting
venules in the submucosa exist as long
sinuses that run longitudinally along the
airways (18,19). Thus soluble materials
need only travel across the mucus and
epithelial cell layers to reach the subepithe-
lial capillary network and have access to the
bronchial circulation. Once in the mucosal
and submucosal circulation, materials can
diffuse back into the interstitium and
lumen in response to local concentration
gradients. Transport of materials toward
peripheral airways and acini is favored since
in the bronchi both the subepithelial capil-
laries and venule sinuses tend to be ori-
ented longitudinally; this favors drainage
toward the pulmonaryvasculature (18).
The fate of dissolved materials also
depends upon where inhaled particles land
in the airways (20). The veins draining the
extrapulmonary airways join the systemic
venous return to the right heart; most veins
from the intrapulmonary airways join the
pulmonary circulation via bronchopul-
monary anastomoses and return to the left
heart (16). As a result, material that dis-
solves in the extrathoracic airways could
either enter the venous sinus network or be
cleared from the lungs but then reappear,
although in a more diluted state, in the
lung parenchyma within the pulmonary
circulation. Materials that enter the intra-
pulmonary circulation have the best chance
to be redistributed to both airway and the
parenchymal tissues. However, materials
that enter the circulation beyond the termi-
nal bronchioles are not redistributed to the
airways. In the normal lung the bronchial
circulation is only 1 to 2% ofthe total car-
diac output. Yet blood flow increases with
general lung injury and in the presence of
inflammatory mediators such as histamine,
platelet activating factor, and prostaglandin
F2a; in some chronic disease conditions
bronchial blood flow may be as much as
one third of the total cardiac output
(16,18).
Lung Parenchyma
Particles that deposit in the nonciliated
portion of the lungs are cleared mechani-
cally, by dissolution, or by the combined
action ofthese processes. During mechani-
cal clearance most particles move toward
the ciliated region within alveolar
macrophages. Some particles also may
move as a result ofa surface tension gradi-
ent due to surfactant that extends from the
alveoli to the airways (21). Other particles
may enter the interstitial tissues (7), partic-
ularly when deposited levels are high (22).
Macrophages are credited with keeping the
alveolar surfaces clean and sterile. These
cells rest on the continuous epithelial layer
ofthe lungs. It is their phagocytic and lytic
potentials that provide most ofthe micro-
bicidal properties ofthe lungs. Rapid endo-
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Figure 1. Mean dissolved 57Co fractions ofthe initial 57Co304 particle mass averaged (with standard deviations) foreach
day of incubation. Data are presented forfour different-sized porous particles phagocytized in canine AM or in cell-free
media. Notethatthevertical scalesdifferforthefourparticle sizes. From Kreyling etal. (37); reprinted bypermission.
cytosis prevents particle penetration
through the alveolar epithelia and facilitates
alveolar-bronchiolar transport. The biology
oflung macrophages has been summarized
(23-26) and a review has emphasized that
many kinds of lung macrophages exist
(27). These include alveolar, airway, con-
nective tissue, pleural, and intravascular
macrophages.
Particles can enter the lung connective
tissue by translocation through type I
pneumocytes (7,28). There are also limited
data that indicate that a few alveolar
macrophages can carry particles into the
interstitium as well (29). Once in the inter-
stitium most particles are phagocytized by
interstitial macrophages; some particles
may remain free temporarily. Interstitial
particles are cleared eventually either
through dissolution or transportation to
regional lymph nodes through lymphatic
pathways. In pulmonary lymph nodes, par-
ticles are cleared with half-lives ranging
from a few days to thousands of days
depending on their solubility.
Intracellular Particle
Dissolution
There is abundant evidence that inorganic
particles such as metal oxides are ingested
by alveolar macrophages (AM). However,
the subsequent fate of these particles is
controversial. Particle dissolution in the
respiratory tract has been recognized as an
important clearance pathway (30,31), but
many authors have suggested that dissolu-
tion occurred extracellularly. For example,
attention has been focused on the proper-
ties of the alveolar lining layer, airway
mucus, or interstitial fluid. This has led to
experimental models estimating dissolution
rates of particles in serum or simulated
lung fluids (32). There is growing evi-
dence that such models are inappropriate.
Studies in dogs showed that various forms
ofinhaled homogeneous cobalt oxide parti-
cles present after several weeks cleared pri-
marily by dissolution ofthe particles in the
lungs, followed by translocation ofthe dis-
solved Co to the blood (33,34). The rate
ofdissolution ofthese cobalt oxide particles
depended on the physical chemical proper-
ties of the particles such as size, density,
specific surface area, and chemical compo-
sition. If the particles were cleared by
reproducible mechanical transport systems,
one would have expected their clearance
rates to be more similar. These particles
dissolve negligibly in serum lung fluid sim-
ulants, and in saline solutions (35,36).
Studies have been carried out on the
dissolution of a family of uniform cobalt
oxide particles within monolayers of
human and canine alveolar macrophages
that were maintained alive and functional
in vitro for more than 2 weeks (37).
Complete phagocytosis ofmoderately solu-
ble, monodisperse 57Co304 test particles of
four sizes was obtained by optimizing the
cell density ofthe monolayer and the parti-
de-to-cell ratio. The soluble fraction ofthe
initial particle mass that was soluble
increased over time when the particles were
ingested byAM but remained constant at a
very small level when in culture medium
alone (Figure 1). Smaller particle sizes had
a faster characteristic intracellular dissolu-
tion rate constant than did larger particles.
The dissolution rates differed between AM
obtained from two human volunteers and
those obtained from six mongrel dogs (38).
These in vitro dissolution rates were very
similar to in vivo translocation rates previ-
ously obtained from human and canine
lung clearance studies after inhalation of
the same or similar monodisperse, homoge-
neous cobalt oxide test particles as part of
an interspecies comparison of lung clear-
ance including seven species (39). We
believe the data show convincingly that an
important clearance mechanism for inhaled
aerosol partides deposited in the lungs is in
vitro dissolution. This is particularly true
for acid soluble particles and at later time
points when the efficiency of mechanical
clearance is diminishing.
Measuring Particle Retention
Once particles have been introduced into
the respiratory tract, the challenge must be
faced ofquantifying the amount and distri-
bution ofretained particles and solubilized
derivatives. Not only are the technological
solutions frequently complex, but the
nature of the problem is frequently
obscure. How should the dose to the respi-
ratory tract be calculated? Should it be
averaged over the whole lung, or should
the local airway or alveolar epithelial dose
be estimated?
An extensive menu of measurement
techniques is available. The approaches
vary in expense, resolution, and the extent
to which the subject must be disturbed.
There are advantages in using nondestruc-
tive, noninvasive methods of detection.
These methods allow repeated measure-
ments on the same animal or person and
thus permit replications and serial measure-
ments, and thus clearance kinetics. For
human experimentation such detection
methods are essential. However, noninva-
sive measurements of retention in whole
animals may provide inadequate detail
about the distribution ofdose to structures
of interest. The greatest precision is
achieved by killing and dissecting animals.
By freezing or drying the lungs, they can be
made rigid and then sliced. It is then possi-
ble physically to divide the respiratory tract
into individual pieces or specific lung com-
partments and analyze the particle content
ofeach piece. Depending on one's patience
and the sensitivity ofthe detection method,
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the distribution ofparticle retention can be
described with increasing detail. These
approaches permit an identification of
anatomical location ofretained particles. A
recent review details many of the available
methods (40).
Actual detection ofparticles in the lung
pieces can rely upon any distinctive prop-
erty of the particles. They may be radioac-
tive, fluorescent, radio-opaque, or
magnetic. They may have a characteristic
visual appearance, which can be identified
with light and electron microscopy. Their
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radiation (ot, 1 y, positrons), and half-lives.
y-emitters penetrate through tissue and
therefore are suitable for making measure-
ments externally. cc- or 13-emitters are bet-
ter suited for producing autoradiographs;
their short path-lengths, which make them
unsuitable for external detection, produce
high resolution images on film in contact
with particle-laden tissue.
Magnetometric
Measurements of Particle
Dissolution
ental or molecular nature may be iden- Some aerosol particles are magnetizable,
I by a repertoire oftechniques includ- and sensitive magnetopneumography can
colorimetry, atomic absorption, measure their concentration and distribu-
ron activation, nuclear magnetic reso- tion in the lungs (42,43). The technique
Se, or electron energy loss spectrometry. consists ofapplying a magnetic field to the
type ofquestion suggests which prop- whole thorax or to localized areas and
s of the particle can be exploited for detecting the resultant alignment of ferro-
and specificity of detection. Various magnetic domains in retained lung parti-
oaches have been reviewed in greater cles. Accumulations of magnetic particles
l (41). have been measured in foundry workers,
Wadioactivity has been used frequently arc welders, coal miners, and asbestos min-
tudies ofparticle deposition because of ers (44). The greatest advantage of this
otential for noninvasive measurement technique is that the duration of measure-
its sensitivity and resolution. ment is not limited by radioactive decay.
dreds of radioisotopes are produced, Measurements can be made as long as suf-
labeled particles can be synthesized ficient dust remains in the lungs. Thus one
a wide spectrum of energies, type of can noninvasively describe clearance kinet-
ics over years (42). Two magnetic dusts
suitable for studying retention in the lung
are Fe304 (magnetite) and y-Fe203 (a mag-
netic form of hematite) (47). Both are
so inert, relatively insoluble at physiological
00. < ^-pH's, and can be aerosolized. The magni-
50. "'< "-LIV tude of the remnant field quantifies the
40- <amount ofdust remaining in the lungs.
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Figure 2. (A): Clearance of yFe2O3 from lungs and liver.
Clearance is measured byfollowing field strength at time
0 (Bo) with time and analyzing with random-effects
regression technique to produce an average curve for
lung clearance and an average curve for liver clearance.
(B): Difference between lung and liver clearance over
time is expressed by lung-clearance-to-liver-clearance
ratio. Ratio departed from 1 with statistical significance
(p<0.05) after 9.5days. From Weinstein and Brain(45).
Reprinted bypermission.
DAYS AFTER MS11LLAT"N
Figure 3. Clearance of Fe3O4 from hamster lungs (n = 6)
using magnetometry. Each point is the mean of the field
strengths immediately after magnetization on the day
shown. SiO2 significantly slows the clearance of Fe3O4,
nonmagnetic iron oxide (Fe203) has a much smaller retard-
ing effect(49).
in the hepatic macrophage or Kupffer cell.
These sister macrophages differ in several
important ways. The alveolar macrophages
are not fixed; rather, they move about on
the alveolar surface seeking particles and
pathogens. Some have asserted that these
macrophages can migrate to the airways
carrying insoluble particles with them. In
contrast, hepatic macrophages are attached
to the endothelial lining of the liver sinu-
soids. No net cell motion for phagocytosis
is needed since the particles are presented
to these cells by the circulating blood. The
rates of particle clearance from each organ
have been compared (45). Pulmonary
clearance includes not only in situ solubi-
lization of iron oxide particles, but may
also represent bulk, mechanical transport
from the respiratory tract by mucociliary
transport or macrophage migration. In the
liver, however, there is no evidence for
either transport mechanism. For instance,
30 years after injection of thorium oxide
(Thorotrast) in patients, particles were still
found in Kupffer cells (46). It would seem
then that particles ingested by Kupffer
cells would disappear primarily by solubi-
lization.
Sprague-Dawley rats were given submi-
crometric y-Fe203 particles suspended in
saline (45). The particles initially were pre-
pared by a combustion of iron pentacar-
bonyl and collected on a filter (46). A
suspension of these particles was injected
intravenously (1.5 mg/kg) or instilled
intratracheally (1 mg/kg) into the lungs.
Individual y-Fe203 particles were 0.1 to
0.2 pm but tended to agglomerate into
chains that were almost always <1 pm.
Magnetometric measurements were then
made (46) and the clearance of particles
from both organs was measured (Figure 2).
Clearance of y-Fe203 particles from the
liver and lungs of rats was followed for 30
days post-injection; over the entire 30-day
Figure 4. Hamster bronchial mucosa with overlying
mucus layer (arrows). The tissue was prepared by slam
freezing, followed by molecular distillation. After infiltra-
tion with Spurr's resin, it was sectioned and examined in
aZeiss CEM 902 electron microscope.There is a 1-pm bar
inthe bottom right.
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Figure 5. Latex particle in situ in hamster covered with
an osmiophilic layer. The tissue was fixed, prepared, and
examined asdescribed in Figure 4.
experiment, clearance from the lungs was
more rapid than from the liver as shown by
the decline of the lung-to-liver ratio from
just under 1.0 at 0 days to 0.65 at 30 days.
The ratio departed from 1.0 with statistical
significance (p < 0.05) after about 9.5
days, as shown in the lower part of the
figure.
We also have used magnetometry to
describe the long-term clearance of iron
oxide from human lungs. Three heavy ciga-
rette smokers and nine nonsmokers inhaled
a trace amount of magnetic dust, Fe304
(42). From periodic measurements with a
sensitive magnetic detector of the amount
ofthis dust remaining in the lungs, a clear-
ance curve was described for each subject.
We found that the dust clearance in smok-
ers was considerably slower than that seen
in the nonsmokers. For example, after
about 1 year, 50% of the dust originally
deposited remained in the lungs of the
smokers, whereas only 10% persisted in the
lungs ofthe nonsmokers.
We also used magnetometry in animals
to look at the impact oftoxic particles such
as ax-quartz (SiO2) to affect the clearance of
magnetic iron oxide (Fe304). Syrian golden
hamsters were intratracheally instilled with
0.2 mg Fe304 alone or in combination
with one ofthe following: 3.75 mg Si02 or
3.75 mg Fe203 (49). Fe3O4 alone had a
clearance half-life (T,,2) of 8.8 ± 1.0 days
(Figure 3). However, in combination with
the 3.75 mg doses ofFe2O3 or SiO2, clear-
ance kinetics were slowed. The 3.75 mg
dose of nonmagnetic Fe203 (a nontoxic
dust) caused the (T12) to rise to 18.4 ± 2.4
days. The 3.75 mg dose of SiO2 slowed
clearance even more dramatically; (TI/2)
increased to 74.1 ± 9.0 days. We conclude
that Fe34 in magnetometry can be used
to evaluate the effects of various mineral
fibers and other particulates on pulmonary
clearance.
Magnetometry has some advantages for
studies of particle dissolution. In the case
ofradioactive particles, even when the par-
ticles are dissolved the atoms or ions
remain radioactive. Thus dissolution may
have occurred, but ifthe components have
been retained in an organ or if they have
been resynthesized in other forms the
radioactivity may persist. For example, iron
oxide can be solubilized, then iron can be
resynthesized in the form of ferritin and
hemosiderin (7). But when the particles
are magnetic, they must remain as macro-
scopic magnetic domains to be detectable
by magnetometry. After dissolution, even if
they persist in a cell or organ, they are no
longer detectable.
Improved Preservation
Methods for Airway and
Alveolar Lining, Layers,
Particles, and Cells
To understand the fate of inhaled particles,
we must preserve precisely anatomic relation-
ships among particles, cells, and the fluids
that line the respiratory tract. Unfortunately,
most routine methods for tissue fixation
involve filling the lungs with liquid or at least
multiple liquid steps. Such methods make it
very likely that particles and cells will be dis-
placed to newlocations orlostaltogether.
Two methods eliminate this possibility.
The first is microwave drying of inflated
lungs, followed by slicing and examination
by fluorescence microscopy or confocal
microscopy. Such dried lungs are never
exposed to any liquid and thus the possibil-
ity ofparticle displacement or loss is elimi-
nated. Naturally, there is loss of detail at
the microscopic or ultrastructural level, but
the essential features of airways and alveoli
are well preserved. In fact, one can rehy-
drate specimens and obtain reasonable
quality light microscopic sections (50).
More recently, we used a technique
commonly known as slam freezing to pre-
serve airways, mucus, and particles and to
prepare them for electron microscopy.
Airways were cut into 3-mm segments
while minimizing any disturbance to the
mucus layer. The segments were opened
longitudinally and mounted so that the
mucus-covered surface could be slam
frozen enface with a LifeCell CF100 cry-
ofixation unit. The airway segment was
then transferred to liquid nitrogen storage
until processed in the LifeCell (MDDC)
freeze drying unit. Dehydration, gaseous
fixations with OS04 (10 mg or 100 mg)
and paraformaldehyde (100 mg), and infil-
tration with Spurr's resin were accom-
plished in the MDDC unit. The airways
were sectioned and stained with toluidine
blue for light microscopy. For ultrastruc-
tural studies, sections were cut at 60 nm
and stained with uranyl acetate and lead
citrate. Thin sections were studied with a
Zeiss CEM902 electron microscope.
Electron spectroscopic imaging enhanced
contrast.
Figure 4 illustrates the preserved mucus
layer of airways, cilia, and epithelial cells
from the bronchus of a hamster. A latex
bead surrounded by an osmiophilic layer is
illustrated in Figure 5. We have consis-
tently found that the mucus layer appears
thicker and more uniform than in previ-
ously published studies. We sometimes
observe two layers as previously described,
but frequently the distinction is less pro-
nounced compared to other fixation and
dehydration methods. We think this is
because the hydrophilic and hydrophobic
components of mucus are far better
preserved.
Electron Energy Loss
Spectroscopy (EELS)
As particles gradually dissolve within
macrophages, soluble ions may become dis-
persed throughout the cell and throughout
tissue. Identifying these materials and
quantifying their distribution is a difficult
task. Electron energy loss spectroscopy
(EELS) can enable us to map the distribu-
tion of elements in relation to the ultra-
structural morphology ofmacrophages and
other lung tissue. This is demonstrated for
cobalt oxide particles within alveolar
macrophages (Figure 6). Moreover, the
anatomic distribution ofcobalt and oxygen
throughout the cell can be described
(Figure 6B,C). Soluble metallic ions also
can be imaged (Figure 7). In this case ham-
ster lung macrophages were incubated with
1 mM solutions ofVCl3. After a 3-hr incu-
bation, the cells were fixed, embedded in
araldite, sectioned at 30 nm, and studied
unstained with the Zeiss CEM902. The
cells incubated with vanadium had large,
irregularly shaped phagolysosomes which
had accumulated and concentrated vana-
dium. Lesser amounts of vanadium were
found in other structures such as mito-
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Figure 6. (A) Cobalt oxide particles are shown within a dog alveolar macrophage recovered by lung lavage. The spatial distribution of cobalt(B) and oxygen(C) throughoutthe cell
can be seen using EELS on a Zeiss CEM 902.
Figure 7. A portion of an alveolar macrophage from a
hamster is shown with numerous irregularly shaped
phagolysosomes. Cells obtained by bronchoalveolar
lavage were cultured with soluble vanadium ions. The
cells were embedded in araldite, sectioned at 30 nm, and
studied unstained with the Zeiss CEM 902. The vanadium
(yellow) has become localized in a phagolysosome-like
organelle.
chondria. We believe that EELS will be a
powerful tool in describing the anatomic
location ofmetal oxide particles and in fol-
lowing the fate ofdissolved elements.
Conclusion
Quantitative assessment of the health risks
resulting from inhaled toxic particles
inevitably depends on understanding the
quantitative and mechanistic aspects of
clearance. In both airways and in alveoli,
we believe that macrophages play an
important role. They ingest insoluble parti-
cles of every type; the disappearance of
these particles then depends on the migra-
tory behavior of macrophages, and espe-
cially on their ability to dissolve particles
within acidic phagolysosomes. New tools
are becoming available to supplement
classic approaches to analyzing macrophage
function. We believe that improved
methods of fixation such as microwave
radiation and slam freezing will preserve
particle-macrophage relationships. We also
believe that new technologies such as mag-
netometry and EELS can be used to study
particle fate. Finally, we believe that disso-
lution of particles within macrophages is a
more important determinant of long-term
clearance kinetics for many mineral dusts,
than is mucociliary transport and the
migratory potential of lung macrophages.
In turn, biopersistence may be correlated
with increased risk ofchronic injury.
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